Hualan Biological Bacterin Inc. (301207.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 11.08B |
| Enterprise Value | 10.74B |
| P/E Ratio | 59.8 |
| PEG Ratio | 0.6 |
| Price/Sales Ratio | 10.08 |
| Price/Book Ratio | 2.27 |
| Enterprise/Revenue | 9.77 |
| Enterprise/EBITDA | 39.02 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.17 |
| Operating Margin | 0.09 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.04 |
Income Statement
| Revenue | 1.2B |
| Revenue/Share | 1.99 |
| Gross Profit | 893.76M |
| EBITDA | 331.64M |
| Net Income | 182.92M |
| Diluted EPS | 0.31 |
Balance Sheet
| Total Cash | 2.81B |
| Total Cash/Share | 4.72 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 4.42 |
| Book Value Per Share | 8.88 |
Price History
| 52-Week Change | 15.91 |
| 52-Week High | 27.88 |
| 52-Week Low | 15.43 |
| Moving Average 50 Days | 17.96 |
| Moving Average 200 Days | 18.92 |
Statistics
| Average Volume | 7.65M |
| Shares Outstanding | 595M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.4 |
| Trailing Annual Dividend Yield | 6.96 |
| Payout Ratio | 4.66 |
| Last Split Factor | 3:2 |
| Last Split Date | June 07, 2023 |
AD
